Capital Flow Monitor · Sponsors · CIK 2146565
Provable Holdings US, Inc.
110 GREENE STREET, NEW YORK, NY, 10012 · 646-741-3165
Other Technology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$13.5M
Sold
$7.5M
% sold
55.6%
Investors
2
Min investment
$1
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-07-23 | D ·current | 506(b) | $13.5M | $7.5M | 55.6% | 2 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Matthew Cohen — Executive Officer / Director, New York, NY
6 other raises
- Declaration Partners Real Estate Fund III-A LP $0 of —
- Declaration Partners Real Estate Fund III LP $0 of —
- APCP Mezz Holdco, LLC $3.1M of $3.7M · 82.7%
- Vida Ventures IV, L.P. $0 of $500.0M · 0.0%
- APCP TX Holdco, LLC $4.5M of $4.5M · 100.0%
- Alphina Therapeutics, Inc. $154K of $10.0M · 1.5%
- Steve Greenblatt — Director, New York, NY
-
John Fichthorn — Director, New York, NY
6 other raises
- Dialectic Life Sciences SPV LLC $4.8M of —
- Dialectic Ventiva SPV LLC $8.0M of —
- VENTIVA, INC. $17.5M of $25.0M · 70.0%
- Bayou Surgical, Inc. $5.0M of $11.0M · 45.5%
- MedTex Elucid Coinvest SPV, LLC $450K of —
- MedTex Voyager Coinvest SPV LLC $500K of —
- Cornelis Jansen — Director, New York, NY
- Derek Penn — Director, New York, NY
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.